Testing HS-20093 with itraconazole in advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial checks if a drug called itraconazole affects how your body processes another drug, HS-20093. It is for people with advanced solid tumors who have tried standard treatments or cannot tolerate them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced solid tumors that standard treatments no longer help or you cannot handle them.
- You have at least one tumor that can be measured by scans (like CT or MRI).
- You can take care of yourself and are up and about (ECOG score 0 or 1).
- Your doctor expects you to live longer than 12 weeks.
- You cannot have any condition that prevents you from taking itraconazole, like severe heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination treatment called HS-20089 for people with advanced solid tumors. The goal is to see if it is safe and how well it works against cancer that has not responded to other treatments.
This trial tests an investigational medicine called HS-20117-2 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it is safe and if it might help shrink or control the tumor.
This trial tests a new drug called HS-20122 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests a new drug called HS-10370 given along with other anticancer treatments for advanced solid tumors that have a specific genetic change called KRAS G12C. The goal is to see if this combination is safe and effective for people who have run out of standard options.
This study tests how a medication called itraconazole affects the levels of a new drug called HS-10504 in your body. It aims to see if taking these together changes how the new drug is absorbed or processed, which helps decide safe dosing for future patients.
This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.